Repetitive dosing of artemisinin and quinine against Plasmodium falciparum in vitro: A simulation of the in vivo pharmacokinetics

被引:6
作者
Bwijo, B
Alin, MH
Abbas, N
Eriksson, O
Bjorkman, A
机构
[1] UPPSALA UNIV, DIV BIOPHARMACEUT & PHARMACOKINET, DEPT PHARM, BIOMED CTR, UPPSALA, SWEDEN
[2] KAROLINSKA INST, DANDERYD HOSP,DIV INFECT DIS, S-18288 DANDERYD, SWEDEN
[3] HUDDINGE UNIV HOSP, HOSP PHARM, S-14186 HUDDINGE, SWEDEN
[4] HUDDINGE UNIV HOSP, UNIT TROP PHARMACOL,DEPT CLIN LAB MED & TECHNOL, S-14186 HUDDINGE, SWEDEN
关键词
artemisinin; in vitro; malaria; Plasmodium falciparum; pharmacokinetics; quinine;
D O I
10.1016/S0001-706X(96)00565-7
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Plasmodium falciparum (F32) parasites were exposed to artemisinin and quinine for 3 and 4 h, respectively, once or twice daily and for 3, 5 or 7 days. Between the peaks the parasites were exposed to trough concentrations. Continuous drug exposure was also assessed for comparison. After drug exposure, the cultures were extended for an observation period of up to 30 days to assess the viability of the parasites remaining after drug exposure. For artemisinin, a critical threshold concentration of 3 x 10(-8) M was required for growth inhibition. Dosing twice daily for at least 5 days was also critical. Prolonging the duration of drug exposure to 7 days further increased the efficacy. For quinine the results were quite different. The concentration dependency of the efficacy was more gradual. On the other hand dosing once daily appeared to be nearly as effective as twice daily and radical clearance was obtained even after 3 days of exposure at peak concentrations of 10(-5) M. A concentration of 10(-6) M provided the same effect if the duration was extended to 7 days. There was a strong similarity between estimated concentrations of free unbound drug required for radical clearance in vitro and those empirically required for clinical efficacy in vivo. This suggests that the in vitro model represents an appropriate model for estimating drug efficacy and pharmacodynamics if the in vitro system is adapted to simulate in vivo pharmacokinetics. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:11 / 22
页数:12
相关论文
共 23 条
[1]   Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients [J].
Alin, MH ;
Ashton, M ;
Kihamia, CM ;
Mtey, GJB ;
Bjorkman, A .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1996, 90 (01) :61-65
[2]   CONCENTRATION AND TIME DEPENDENCY OF ARTEMISININ EFFICACY AGAINST PLASMODIUM-FALCIPARUM IN-VITRO [J].
ALIN, MH ;
BJORKMAN, A .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1994, 50 (06) :771-776
[3]  
BJORKMAN A, 1991, B WORLD HEALTH ORGAN, V69, P456
[4]  
BRUCHFELD J, 1991, TROP MED PARASITOL, V42, P153
[5]  
BUNNAG D, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P534
[6]   THE PHARMACOKINETICS OF A SINGLE-DOSE OF ARTEMISININ IN HEALTHY VIETNAMESE SUBJECTS [J].
DUC, DD ;
DEVRIES, PJ ;
KHANH, NX ;
BINH, LN ;
KAGER, PA ;
VANBOXTEL, CJ .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1994, 51 (06) :785-790
[7]  
EDLUND PO, 1984, ACTA PHARM SUEC, V21, P223
[8]   QUANTIFICATION OF QUININE IN HUMAN-SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
EDSTEIN, M ;
STACE, J ;
SHANN, F .
JOURNAL OF CHROMATOGRAPHY, 1983, 278 (02) :445-451
[9]  
ERIKSSON O, 1993, TROP MED PARASITOL, V42, P153
[10]   UPTAKE OF [H-3] DIHYDROARTEMISININE BY ERYTHROCYTES INFECTED WITH PLASMODIUM-FALCIPARUM INVITRO [J].
GU, HM ;
WARHURST, DC ;
PETERS, W .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1984, 78 (02) :265-270